Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample type	Gender
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	109	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	468	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	607	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	1919	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	2151	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	2172	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	2446	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	2564	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	2738	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	2769	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	2793	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	2906	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	2912	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	3072	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	3322	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	3547	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	3578	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	3617	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	3657	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	3661	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	3912	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	3925	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4090	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4148	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4153	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4227	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4291	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4323	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4396	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4437	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4489	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4499	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4505	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4617	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4719	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4738	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4762	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4794	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4844	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4848	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4882	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4900	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4972	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	4973	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5017	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5047	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5132	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5187	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5201	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5211	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5286	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5315	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5349	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5357	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5383	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5421	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5435	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5438	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5445	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5483	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5543	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5578	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5582	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5643	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5650	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5664	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5688	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5689	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5761	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5780	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5807	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5827	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	5879	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6019	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6060	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6154	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6239	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6271	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6300	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6355	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6386	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6472	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6496	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6506	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6532	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6618	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6695	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6713	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6721	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6788	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6902	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6903	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6907	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6927	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6979	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6981	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6989	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	6990	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7062	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7152	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7197	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7217	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7420	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7434	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7482	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7511	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7518	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7525	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7554	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7619	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7627	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7637	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7697	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7710	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7821	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7835	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7846	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7864	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7887	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7904	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7908	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7924	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7946	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7946	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7948	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7951	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7959	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	7974	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8010	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8013	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8053	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8054	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8059	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8060	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8089	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8093	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8099	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8100	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8113	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8150	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8164	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8165	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8182	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8189	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8199	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8200	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8203	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8213	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8224	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8226	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8271	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8284	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8286	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8287	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8316	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8346	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8347	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8359	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8372	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8378	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8400	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8411	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8424	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8430	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8442	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8457	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8495	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8580	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8596	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8605	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8654	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8664	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8685	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8699	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8714	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8757	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	8801	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	9048	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	9065	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	9089	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	9124	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	9146	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	9288	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	9428	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	9436	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	9465	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	9493	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	9769	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	10148	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	10252	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	10328	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	10335	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	10376	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	10755	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	10756	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	10867	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	10893	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	10945	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	11061	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenylacetate	11201	Peak area normalized	Sample	female

Return to search page